|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 21.61 USD | -1.59% |
|
+0.37% | -6.08% |
| 09-28 | Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing | MT |
| 09-20 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DMRA | Delayed | |
CBOE
| DMRA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 22.85 | 24.9 | 34.14 |
| Spread/Res. | -5.43% | -13.21% | -36.70% |
| Spread/Supp. | +17.25% | +17.25% | +28.86% |
| Support | 18.43 | 18.43 | 16.77 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
